Journey Medical dermatology revenue plus Emrosi near-term sales and a rare pediatric disease PRV from Zycubo approval. See ...
Does āBugoniaā turn out to be a tense thriller about delusion, or a sci-fi movie about aliens?
Sepsis, a life-threatening response to infection, is a major cause of death in U.S. hospitals, and early treatment is critical. The flag prompted the charge nurse to instruct Hart to room the patient ...
MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" the "Company," "we" or "our") today announced its fourth quarter and full-year 2025 financial results and other key updates for the ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, ...
Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 Million Completed Galleri PMA Submission to FDA Shared Topline ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
The Allspring Large Cap Growth Fund underperformed the Russell 1000 Growth Index during the fourth quarter. Read more here.
Commercial adoption of the Galleri multi-cancer early detection test remained a bright spot, with more than 185,000 tests ...
This is an important study that identifies the developmental time window during which re-expression of TCF4 mutated in Pitt-Hopkins syndrome, can rescue phenotypic features of brain function in a TCF4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results